Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Thomas

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
International Journal for Parasitology. Drugs and Drug Resistance|May 16, 2026
Furoxan derivatives with antimalarial activity that disrupt P. falciparum endoplasmic reticulum calcium homeostasisLeandro da Costa Clementino, Paula J Bartlett, Guilherme F S Fernandes, et al.
Journal of Medicinal Chemistry|May 23, 2012
Protein-ligand crystal structures can guide the design of selective inhibitors of the FGFR tyrosine kinaseRichard A Norman, Anne-Kathrin Schott, David M Andrews, et al.
Analytical Biochemistry|December 19, 2009
Use of thermal melt curves to assess the quality of enzyme preparationsGregory J Crowther, Panqing He, Philip P Rodenbough, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Imidazo[1,2-a]pyridines: a potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisationMalcolm Anderson, John F Beattie, Gloria A Breault, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitorsKate F Byth, Nicola Cooper, Janet D Culshaw, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 3, 2023
Endothelial mechanisms for inactivation of inflammation-induced hyperpermeabilityPrerna R Nepali, Pía C Burboa, Mauricio A Lillo, et al.
Journal of Biomolecular Screening|May 28, 2009
Buffer optimization of thermal melt assays of Plasmodium proteins for detection of small-molecule ligandsGregory J Crowther, Alberto J Napuli, Andrew P Thomas, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2021
New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in <i>Leishmania</i>: Calcium Dysregulation, Mitochondrial Dysfunction, and Cell DeathAngela M A Velásquez, Paula J Bartlett, Irwin A P Linares, et al.
Cancer Research|August 17, 2002
ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administrationStephen R Wedge, Donald J Ogilvie, Michael Dukes, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2008
Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitorsMalcolm Anderson, David M Andrews, Andy J Barker, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
International Journal for Parasitology. Drugs and Drug Resistance|May 16, 2026
Furoxan derivatives with antimalarial activity that disrupt P. falciparum endoplasmic reticulum calcium homeostasisLeandro da Costa Clementino, Paula J Bartlett, Guilherme F S Fernandes, et al.
Journal of Medicinal Chemistry|May 23, 2012
Protein-ligand crystal structures can guide the design of selective inhibitors of the FGFR tyrosine kinaseRichard A Norman, Anne-Kathrin Schott, David M Andrews, et al.
Analytical Biochemistry|December 19, 2009
Use of thermal melt curves to assess the quality of enzyme preparationsGregory J Crowther, Panqing He, Philip P Rodenbough, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Imidazo[1,2-a]pyridines: a potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisationMalcolm Anderson, John F Beattie, Gloria A Breault, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitorsKate F Byth, Nicola Cooper, Janet D Culshaw, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 3, 2023
Endothelial mechanisms for inactivation of inflammation-induced hyperpermeabilityPrerna R Nepali, Pía C Burboa, Mauricio A Lillo, et al.
Journal of Biomolecular Screening|May 28, 2009
Buffer optimization of thermal melt assays of Plasmodium proteins for detection of small-molecule ligandsGregory J Crowther, Alberto J Napuli, Andrew P Thomas, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2021
New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in <i>Leishmania</i>: Calcium Dysregulation, Mitochondrial Dysfunction, and Cell DeathAngela M A Velásquez, Paula J Bartlett, Irwin A P Linares, et al.
Cancer Research|August 17, 2002
ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administrationStephen R Wedge, Donald J Ogilvie, Michael Dukes, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2008
Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitorsMalcolm Anderson, David M Andrews, Andy J Barker, et al.
Pageof 7